Brivaracetam Tablets 50 Mg – BRIVUM-50 Tablets
₹3,600.00
Brivaracetam 50mg – 10*10 ALU
Brivaracetam Tablets 50 Mg – Optimized Treatment for better epilepsy management
BRIVUM-50 – Brivaracetam 50 mg, Brivaracetam is an antiepileptic drug (AED) designed for the Treatment of partial-onset seizures, including those with or without secondary generalization. It binds to the synaptic vesicle protein SV2A, crucial for neurotransmitter release. This action helps stabilize neuronal excitability, making it effective in seizure control.
Brivaracetam is a newer-generation AED with a favorable pharmacokinetic profile. It offers good bioavailability and predictable action. Compared to older antiepileptic medications, it has a relatively lower risk of cognitive side effects.
Recommended by specialists:
✅ Neurologist: Primary specialists for diagnosing and managing epilepsy and seizure disorders are often prescribed as monotherapy or adjunct therapy for partial-onset seizures.
Key benefits of Brivaracetam Tablets 50 Mg – BRIVUM-50 Tablets:
✅ Targeted action for seizure control: Brivaracetam selectively binds to synaptic vesicle protein 2A (SV2A), which alleviates the release of neurotransmitters, helping to manage abnormal electrical activity in the brain.
✅ Well-tolerated safety profile with convenient dosing: Available in tablet dosage form, making it suitable for adults and children, with minimal interactions and better tolerability
✅ Fast and consistent effect: Brivaracetam 50mg tablet provides rapid onset of action and steady seizure control with minimal side effects, ensuring patients’ better quality of life.
Recommended by specialists:
✅ Neurologist: Primary specialists for diagnosing and managing epilepsy and seizure disorders are often prescribed as monotherapy or adjunct therapy for partial-onset seizures.
Indications-
✅ Partial-onset seizures (with or without secondary generalization)
✅ Epilepsy in adults and children aged 4 years and older
✅ Adjunctive therapy for treatment-resistant epilepsy
Related Products
Proin volutpat vitae libero at tincidunt. Maecenas sapien lectus, vehicula vel euismod sed, vulputate
Proin volutpat vitae libero at tincidunt. Maecenas sapien lectus, vehicula vel euismod sed, vulputate
Fawn Incor Private Limited is one of the fastest-growing and rapidly developing PCD Pharma Franchise Company in India. With proven expertise in the healthcare sector, we cater to the diverse needs of our customers by offering a wide range of general and specialty divisions, including Gynecology, Dermatology, Orthopedics, Neurology, Ophthalmology, Cardiac-Diabetic care, and PPIs.
Panchkula (Admin Office)
Plot No 404, Basement, Industrial Area, Phase I, Panchkula (HR) 134113
Mumbai(Corporate Office)
3rd Floor, Tree House, Raghuvanshi Mills, Lower Parel (West), Mumbai – 400013 India
Netherlands (Overseas)
Fawn Inc. 217, Lichstraat, Eindhoven, Netherlands
+91-9888099264
+91 6280 986 280
+91-7814201203
info@fawnincor.com
Fawnincor@gmail.com
Copyright © Fawn Incor Pvt. Ltd. 2024. All Rights Reserved.
